Search Results

Displaying Results 551-575 of 1115 "'IX'"

Apr 02, 2026, 09:50 ET Bioretec Ltd publishes an exemption document relating to its rights issue

Regulation (EU) 2017/1129 (the "Prospectus Regulation"). The Exemption Document has been prepared in accordance with the requirements of Annex IX to the Prospectus Regulation.The Exemption Document is available on Bioretec's website at

More news about: Bioretec


Apr 02, 2026, 09:47 ET Bioretec Ltd publishes an exemption document relating to its rights issue

Regulation (EU) 2017/1129 (the "Prospectus Regulation"). The Exemption Document has been prepared in accordance with the requirements of Annex IX to the Prospectus Regulation.The Exemption Document is available on Bioretec's website at

More news about: Bioretec


Apr 01, 2026, 23:23 ET Highland Opportunities and Income Fund Announces the Regular Monthly Distribution

(vii) variations in rental income, neighborhood values or the appeal of property to tenants; (viii) the availability of financing and (ix) changes in interest rates and leverage.Illiquidity of Investments Risk. The investments made by the Fund may be illiquid,

More news about: Highland Opportunities and Income Fund


Apr 01, 2026, 14:31 ET National Sports Law Leader Gabe Feldman Joins the Emergetic Sports team to implement Project Northstar

college sports—balancing institutional control, donor alignment, athlete compensation, and long-term support for all sports including Olympic and Title IX programs and their student athletes. More on Project Northstar can be found at

More news about: Emergetic Sports


Apr 01, 2026, 08:30 ET AES Announces Successful Completion of Consent Solicitation for its 2028 Notes

restrictions during the pendency of the Transaction that may impact AES' ability to pursue certain business opportunities or strategic transactions; (ix) significant transaction costs associated with the Transaction; (x) the possibility that the Transaction may be more expensive to complete than anticipated,

More news about: The AES Corporation


Apr 01, 2026, 08:30 ET IPALCO Enterprises, Inc. Announces Extension of Expiration Time for Previously Announced Consent Solicitations

during the pendency of the Transaction that may impact AES' or IPALCO's ability to pursue certain business opportunities or strategic transactions; (ix) significant transaction costs associated with the Transaction; (x) the possibility that the Transaction may be more expensive to complete than anticipated,

More news about: IPALCO Enterprises


Apr 01, 2026, 08:30 ET DPL LLC Announces Extension of Expiration Time for Previously Announced Consent Solicitation

restrictions during the pendency of the Transaction that may impact AES' or DPL's ability to pursue certain business opportunities or strategic transactions; (ix) significant transaction costs associated with the Transaction; (x) the possibility that the Transaction may be more expensive to complete than anticipated,

More news about: DPL LLC


Mar 31, 2026, 20:00 ET Hanon Systems Supplies Highly Integrated Cooling Entity for Electric Vehicles

contribute to a more sustainable future."The highly integrated cooling entity developed by Hanon Systems was first deployed in BMW's fully electric iX3 SUV model. Designed for electric vehicles, the highly integrated cooling entity manages the thermal needs of multiple vehicle subsystems through an

More news about: Hanon Systems


Mar 31, 2026, 16:30 ET Blue Owl Capital Announces $2.9 Billion Final Close for Asset Special Opportunities Fund

today announced the final close of Blue Owl Asset Special Opportunities Fund IX ("ASOF IX" or "the Fund") with approximately $2.9 billion of total capital commitments, exceeding its original target of $2.5 billion. ASOF IX is a diversified, asset-backed opportunistic strategy that employs a flexible

More news about: Blue Owl Capital


Mar 31, 2026, 08:03 ET McCormick to Combine with Unilever's Foods Business, Creating a Preeminent Global Flavor-Focused Company

anticipated combined company revenues, earnings, cash flows, capital expenditures, indebtedness and other financial metrics of the combined company; (ix) the risk that the anticipated ownership percentages of McCormick shareholders, Unilever shareholders and Unilever following the closing of the transaction

More news about: McCormick & Company, Incorporated


Mar 31, 2026, 07:55 ET McCormick to Combine with Unilever's Foods Business, Creating a Preeminent Global Flavor-Focused Company

anticipated combined company revenues, earnings, cash flows, capital expenditures, indebtedness and other financial metrics of the combined company; (ix) the risk that the anticipated ownership percentages of McCormick shareholders, Unilever shareholders and Unilever following the closing of the transaction

More news about: McCormick & Company, Incorporated


Mar 31, 2026, 07:51 ET Latch (Now DOOR) Files 2025 Annual Report and Provides Financial Update

(v) restructuring costs, (vi) transaction-related costs, (vii) impairment of assets, (viii) non-ordinary course legal fees and settlement reserves, (ix) stock-based compensation expense and (x) gain or loss on extinguishment of debt. The most directly comparable GAAP measure is net loss. We believe excluding

More news about: DOOR


Mar 30, 2026, 17:01 ET Sun Life completes remaining equity interest purchases of BGO and Crescent Capital. Sun Life also announces acquisition of Bell Partners, a leading multifamily real estate investment manager.

the number of shares outstanding; (vii) no material changes to our hedging program; (viii) hedging costs that are consistent with our expectations; (ix) no material assumption changes; and (x) no material accounting standard changes. In addition, Sun Life's Medium-Term Objectives and SLC's medium-term

More news about: Sun Life Financial Inc. - Financial News


Mar 30, 2026, 17:01 ET Sun Life completes remaining equity interest purchases of BGO and Crescent Capital. Sun Life also announces acquisition of Bell Partners, a leading multifamily real estate investment manager.

the number of shares outstanding; (vii) no material changes to our hedging program; (viii) hedging costs that are consistent with our expectations; (ix) no material assumption changes; and (x) no material accounting standard changes. In addition, Sun Life's Medium-Term Objectives and SLC's medium-term

More news about: Sun Life Financial Inc. - Financial News


Mar 30, 2026, 08:30 ET AES Announces Extension of Consent Solicitation for its 2028 Notes

restrictions during the pendency of the Transaction that may impact AES' ability to pursue certain business opportunities or strategic transactions; (ix) significant transaction costs associated with the Transaction; (x) the possibility that the Transaction may be more expensive to complete than anticipated,

More news about: The AES Corporation


Mar 30, 2026, 08:30 ET DPL LLC Announces Extension of Expiration Time for Previously Announced Consent Solicitation

restrictions during the pendency of the Transaction that may impact AES' or DPL's ability to pursue certain business opportunities or strategic transactions; (ix) significant transaction costs associated with the Transaction; (x) the possibility that the Transaction may be more expensive to complete than anticipated,

More news about: DPL LLC


Mar 30, 2026, 08:30 ET IPALCO Enterprises, Inc. Announces Extension of Expiration Time for Previously Announced Consent Solicitations

during the pendency of the Transaction that may impact AES' or IPALCO's ability to pursue certain business opportunities or strategic transactions; (ix) significant transaction costs associated with the Transaction; (x) the possibility that the Transaction may be more expensive to complete than anticipated,

More news about: IPALCO Enterprises


Mar 28, 2026, 15:15 ET Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity

doctor or other healthcare provider about Taltz and how to take it. Your doctor is the best person to help you decide if Taltz is right for you.IX CON BS 20AUG2024ZEPBOUND INDICATIONS AND SAFETY SUMMARY WITH WARNINGS Zepbound® (ZEHP-bownd) is an injectable

More news about: Eli Lilly and Company


Mar 27, 2026, 17:00 ET Keurig Dr Pepper Declares Offer for JDE Peet's Unconditional

respective management from business operations; (viii) risks relating to potential litigation that arises as a result of the proposed transactions; and (ix) risks and uncertainties discussed in KDP's and JDE Peet's press releases and public filings.Neither KDP nor JDE Peet's, nor any of their advisors,

More news about: Keurig Dr Pepper


Mar 27, 2026, 08:50 ET Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of up to approximately EUR 14.8 million and publishes the terms and conditions of the rights issue

the "Prospectus Regulation"). The Exemption Document will be prepared in the Finnish language and in accordance with the requirements of Annex IX of the Prospectus Regulation. Bioretec will publish the Exemption Document on or about 2 April 2026 before the commencement of the Subscription Period.

More news about: Bioretec


Mar 27, 2026, 08:44 ET Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of up to approximately EUR 14.8 million and publishes the terms and conditions of the rights issue

the "Prospectus Regulation"). The Exemption Document will be prepared in the Finnish language and in accordance with the requirements of Annex IX of the Prospectus Regulation. Bioretec will publish the Exemption Document on or about 2 April 2026 before the commencement of the Subscription Period.

More news about: Bioretec


Mar 27, 2026, 07:00 ET HONEYWELL ANNUAL SHAREOWNERS MEETING SET FOR MAY 22, 2026

capital structures in connection with the spin-off transaction, including the future availability of credit and factors that may affect such availability; (ix) the ability to achieve anticipated credit ratings in connection with the spin-off transaction; (x) the ability to achieve anticipated tax treatments

More news about: Honeywell


Mar 27, 2026, 06:45 ET Neutrogena®, Aveeno® and Rogaine® Release New Dermatology Research and Clinical Skincare Innovations on Healthy Aging, Moisturization, Sun Protection and Acne

Management with Enhanced Skin Tolerance. Presented at: American Academy of Dermatology Annual Meeting; March 27-31, 2026; Denver, Colorado.ix Luts T, DeVoe C, Williams J. Formulating high efficacy sunscreens with bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT): a new sunscreen filter

More news about: Kenvue Inc.


Mar 26, 2026, 13:46 ET The Finnish Financial Supervisory Authority has granted Stephen Industries Inc Oy and Kustaa Poutiainen a permanent exemption from the obligation to launch a mandatory public takeover bid

accordance with Article 1(4) (db) of the Prospectus Regulation. The exemption document will be prepared in accordance with the requirements of Annex IX to the Prospectus Regulation. The exemption document does not constitute a prospectus under the Prospectus Regulation and will neither be reviewed nor

More news about: Bioretec


Mar 26, 2026, 13:42 ET The Finnish Financial Supervisory Authority has granted Stephen Industries Inc Oy and Kustaa Poutiainen a permanent exemption from the obligation to launch a mandatory public takeover bid

accordance with Article 1(4) (db) of the Prospectus Regulation. The exemption document will be prepared in accordance with the requirements of Annex IX to the Prospectus Regulation. The exemption document does not constitute a prospectus under the Prospectus Regulation and will neither be reviewed nor

More news about: Bioretec


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.